These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9603699)

  • 21. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
    van Breukelen-van der Stoep DF; Zijlmans J; van Zeben D; Klop B; van de Geijn GJ; van der Meulen N; Hazes M; Birnie E; Castro Cabezas M
    Scand J Rheumatol; 2015; 44(6):443-8. PubMed ID: 26169960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage of motivational readiness: predictive ability for exercise behavior.
    Young DR; King AC; Sheehan M; Stefanick ML
    Am J Health Behav; 2002; 26(5):331-41. PubMed ID: 12206443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Deficits in adherence on all levels. Current need of interventions in primary, secondary, and tertiary prevention of cardiovascular diseases].
    Huy C; Thiel A; Diehm C; Schneider S
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2119-24. PubMed ID: 20960382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment adherence in cardiovascular prevention].
    Ambrosetti M; Angelino E; Faggiano P; Fattirolli F; Favretto G; Febo O; Greco C; La Rovere MT; Mureddu GF; Scardina G; Pedretti RFE
    G Ital Cardiol (Rome); 2018 Oct; 19(10 Suppl 3):41S-56S. PubMed ID: 30353207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?
    Berra K
    J Cardiovasc Nurs; 2011; 26(2):145-67. PubMed ID: 21076315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage of change movement across three health behaviors: the role of self-efficacy.
    O'Hea EL; Boudreaux ED; Jeffries SK; Carmack Taylor CL; Scarinci IC; Brantley PJ
    Am J Health Promot; 2004; 19(2):94-102. PubMed ID: 15559709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Need for a paradigm shift: the importance of risk factor reduction therapy in treating patients with cardiovascular disease.
    Smith SC
    Am J Cardiol; 1998 Nov; 82(10B):10T-13T. PubMed ID: 9860367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concept analysis of adherence in the context of cardiovascular risk reduction.
    Cohen SM
    Nurs Forum; 2009; 44(1):25-36. PubMed ID: 19187051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing adherence to prescribed exercise: structured behavioral interventions in clinical exercise programs.
    Woodard CM; Berry MJ
    J Cardiopulm Rehabil; 2001; 21(4):201-9. PubMed ID: 11508179
    [No Abstract]   [Full Text] [Related]  

  • 30. Multimedia educational interventions for consumers about prescribed and over-the-counter medications.
    Ciciriello S; Johnston RV; Osborne RH; Wicks I; deKroo T; Clerehan R; O'Neill C; Buchbinder R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008416. PubMed ID: 23633355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cultural factors and patients' adherence to lifestyle measures.
    Serour M; Alqhenaei H; Al-Saqabi S; Mustafa AR; Ben-Nakhi A
    Br J Gen Pract; 2007 Apr; 57(537):291-5. PubMed ID: 17394732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure patient adherence: epidemiology, cause, and treatment.
    Corotto PS; McCarey MM; Adams S; Khazanie P; Whellan DJ
    Heart Fail Clin; 2013 Jan; 9(1):49-58. PubMed ID: 23168317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to medication, diet, and activity recommendations: from assessment to maintenance.
    Burke LE; Dunbar-Jacob J
    J Cardiovasc Nurs; 1995 Jan; 9(2):62-79. PubMed ID: 9197995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of smoking from the psychological medicine perspective].
    Müller MJ; Neuser J
    Z Arztl Fortbild (Jena); 1995 Oct; 89(5):473-88. PubMed ID: 8578775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of a multimodal intervention trial to promote lifestyle factors associated with the prevention of cardiovascular disease in menopausal and postmenopausal Australian women.
    Anderson D; Mizzari K; Kain V; Webster J
    Health Care Women Int; 2006 Mar; 27(3):238-53. PubMed ID: 16524854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral medicine in the prevention and treatment of cardiovascular disease.
    Graves KD; Miller PM
    Behav Modif; 2003 Jan; 27(1):3-25. PubMed ID: 12587257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Connected Health Interventions for Adherence to Cardiovascular Disease Prevention: A Scoping Review.
    Agher D; Sedki K; Tsopra R; Despres S; Jaulent MC
    Appl Clin Inform; 2020 Aug; 11(4):544-555. PubMed ID: 32814353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention and patient's compliance. Two key factors to deal with non communicable chronic diseases].
    Téllez A
    Rev Med Chil; 2004 Dec; 132(12):1453-5. PubMed ID: 15743155
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.